# Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)

> **NCT00312806** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 2000 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)

## Interventions

- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT00312806
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-03
- **Final completion:** 2007-07
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2012-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312806, "Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00312806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*